A scientist in a white lab coat and blue gloves holds a small vial up to the light while holding a yellow tray in a laboratory.
Explore key research and community highlights in the Institute's 2024 annual report
I am pleased to share with you the 2024 Annual Report of the Berthiaume Institute for Precision Health. Since our founding in 2021, BIPH has been driven by a singular mission: to develop transformative technologies that detect, prevent, and treat disease, promote wellness, and reduce health disparities. This mission requires us to bring together interdisciplinary teams of engineers, biologists, data scientists, and clinicians to tackle complex challenges—from advancing cancer diagnostics, to preventing global infectious diseases, to monitoring environmental hazards with greater precision.

In the report, we highlight recent breakthroughs and emerging innovations. These include novel detection platforms—such as an “electronic nose” for pathogen identification and next-generation tools for breast cancer diagnosis—as well as engineered tissues and therapeutic delivery systems that offer more efficient and cost-effective healthcare solutions. At the same time, BIPH is building strong university–community partnerships to address pressing societal needs: from new strategies to combat the opioid crisis, to technologies that detect and mitigate environmental toxins like lead, to data-integrated platforms that empower local decision-makers. By taking our research beyond campus—and engaging international collaborators, patient advocates, and field researchers—we aim to scale the impact of Notre Dame technologies to improve lives around the world.

A key part of our mission is to educate and empower the next generation of leaders in precision health. Through graduate fellowships, hands-on training, professional development, and technology incubation and support, we are equipping researchers across all career stages to translate pioneering science into real-world impact. This report also celebrates the achievements of our faculty, major funding milestones, and our strategic plans for continued growth—reflecting both Notre Dame’s enduring commitment to interdisciplinary research and our shared vision of serving the common good.

Thank you for taking the time to explore the exceptional work being carried out by our interdisciplinary investigators of the Berthiaume Institute for Precision Health. We look forward to building on our momentum and expanding our collaborative efforts to transform lives and communities—locally and globally—as we continue to make Notre Dame a true Force for Good in a world in need.

Sincerely,

Headshot of a man with short brown hair, a brown beard, and blue eyes. He wears a gray shirt and has a serious expression.
 
Matthew J. Webber
Acting Director, Berthiaume Institute for Precision Health
Keating-Crawford Collegiate Professor of Engineering
 
 
 
 

View the 2024 Annual Report


Read the 2023 Annual Report

Read the 2022 Annual Report